… old SSRI fluvoxamine may be new hope for the COVID-19 pandemic [22]. In this article, we
review the mechanisms of action of fluvoxamine and other antidepressants for COVID-19 and …

… Fluvoxamine is also an agonist for the sigma-1 receptor, through which it controls …
mechanisms of action of fluvoxamine and other SSRIs that could play a role in COVID-19 treatment. …

… we cannot conclude the beneficial effects of fluvoxamine for COVID-19. However, several
non-… Considering the role of sigma-1 receptor in mechanisms of action of SARS-CoV-2 [10, 11], …

… action of fluvoxamine for COVID-19 are currently unknown. In 1996, we reported that fluvoxamine
… sigma-1 receptor in the mechanisms of its action [5]. Subsequent studies suggest that …

… The authors mentioned that the findings of their study, together with fluvoxamine's safety, …
of COVID-19. We wish to comment further to raise awareness of the fact that fluvoxamine has a …

… to demonstrate that fluvoxamine is effective for the treatment of mild to moderate COVID-19. …
from earlier trials on fluvoxamine? A more practical question for frontline clinicians is: Does …

… virus, neither fluvoxamine nor fluoxetine appeared promising … of the potential mechanism
of action assessed in these … generic selective serotonin reuptake inhibitors for COVID-19. …

… The scare of COVID-19 is high and a drug like fluvoxamine is … between COVID-19 and
psychiatric disorders (2). Almost 1 in 5 … Its mechanism of action may include the fact that it can …

… medications for mild to moderate COVID-19. Between August 25, … fluvoxamine; participants
were 30 years or older with confirmed SARS-CoV-2 infection and at least 2 acute COVID-19 …

… fluvoxamine as an early treatment for mild COVID‐19 in 1649 self‐isolated people at home
(outpatients). All studies compared fluvoxamine to … mechanisms of action of fluvoxamine and …